Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:affects |
peritoneum
|
| gptkbp:associated_with |
gptkb:pleural_mesothelioma
|
| gptkbp:caused_by |
asbestos exposure
|
| gptkbp:clinical_trial |
Phase IV
Phase II Phase III Phase I |
| gptkbp:death |
5-year survival rate
10% to 20% |
| gptkbp:diagnosis |
biopsy
imaging tests poor prognosis fibulin-3 mesothelin |
| gptkbp:epidemiology |
more common in men
associated with occupational exposure increased incidence in certain regions |
| gptkbp:financial_support |
counseling services available
support groups available |
| gptkbp:first_described_by |
1960s
|
| gptkbp:genetic_studies |
CDKN2 A deletion
BAP1 mutation |
| gptkbp:historical_aspect |
first recognized in the 20th century
linked to industrial exposure |
| https://www.w3.org/2000/01/rdf-schema#label |
peritoneal mesothelioma
|
| gptkbp:legislation |
asbestos litigation
compensation claims possible |
| gptkbp:number_of_stages |
stage I
stage IV stage II stage III |
| gptkbp:occurs_in |
rare
|
| gptkbp:public_awareness |
gptkb:Mesothelioma_Awareness_Day
educational resources available |
| gptkbp:research_focus |
gptkb:immunotherapy
targeted therapy |
| gptkbp:risk_factor |
male gender
older age |
| gptkbp:symptoms |
nausea
weight loss abdominal pain fever night sweats abdominal swelling |
| gptkbp:treatment |
gptkb:surgery
palliative care clinical trials radiation therapy chemotherapy HIPEC surgical resection may improve outcomes variable response to chemotherapy |
| gptkbp:bfsParent |
gptkb:malignant_mesothelioma
|
| gptkbp:bfsLayer |
7
|